CD19/CD22 CAR-T as First-line Consolidation in Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Remote Monitoring and Symptom Management Digital Application
- Status
- RECRUITING
- Phase
- NA
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
- Status
- NOT_YET_RECRUITING
- Phase
- NA
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)
- Status
- RECRUITING
- Phase
- N/A
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
- Status
- RECRUITING
- Phase
- NA
CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
- Status
- RECRUITING
- Phase
- NA
A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Precision Physical Exercise for Personalized Onco-Hematology.
- Status
- NOT_YET_RECRUITING
- Phase
- NA